iBio Inc. (IBIO) |
|
1.96 -0.12 (-5.77%)
|
07-02 16:00 |
|
Open: |
1.9 |
Pre. Close: |
2.08 |
|
High:
|
2.06 |
Low:
|
1.9 |
|
Volume:
|
8,810,873 |
Market Cap:
|
235M |
|
|
|
|
iBio, Inc., a biotechnology company, provides product development and manufacturing services to clients, collaborators, and third-party customers in the United States and internationally. The company's services cover the stages of pre-clinical development, regulatory approval, commercial product launch, and on-going commercial phase requirements. Its lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. The company is also developing vaccine candidates for third parties. It has a license agreement with the University of Natural Resources and Life Sciences, Vienna; a strategic relationship with Beijing CC-Pharming Ltd.; and collaboration agreements with AzarGen Biotechnologies (Pty) Ltd, The Texas A&M University System, and Fraunhofer Center for Molecular Biotechnology. In addition, the company offers a range of product and process development, analytical, and manufacturing services. iBio, Inc. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.054 - 2.067 |
2.067 - 2.076 |
|
Low:
|
1.892 - 1.907 |
1.907 - 1.919 |
|
Close:
|
1.939 - 1.963 |
1.963 - 1.98 |
|
Technical analysis |
as of: 2020-07-02 4:31:11 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 2.56  One year: 3.15 |
| Support: |
Support1: 1.38 Support2: 1.15 |
| Resistance: |
Resistance1: 2.20 Resistance2: 2.70 |
| Pivot: |
1.74  |
| Moving Average: |
MA(5): 2.17 MA(20): 1.68
MA(100): 1.26 MA(250): 0.76 |
| MACD: |
MACD(12,26): 0.18 Signal(9): 0.13 |
| Stochastic oscillator: |
%K(14,3): 53.54 %D(3): 62.59 |
| RSI: |
RSI(14): 58.25 |
| 52-week: |
High: 3.40 Low: 0.05 Change(%): 184.1 |
| Average Vol(K): |
3-Month: 1538992 10-Days: 3337186 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.IBIO has closed below upper band by 33.2%. Bollinger Bands are 46.7% wider than normal. The large width of the bands suggest high volatility as compared to IBIO's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Thu, 02 Jul 2020
Why iBio Is an Excellent Pandemic Spec Play - Investorplace.com
Thu, 02 Jul 2020
Buy or Sell iBio, Inc. (IBIO) Stock Now? Don't Try to Be a Top Gun - The News Heater
Wed, 01 Jul 2020
Market Reactions to Ibio Inc (IBIO) Stock Getting a Neutral Rating - InvestorsObserver
Tue, 30 Jun 2020
Is Ibio Inc (IBIO) Stock a Top Performer in the Healthcare Sector? - InvestorsObserver
Tue, 30 Jun 2020
iBio Inc. (AMEX:IBIO) Stock is Soaring, Here is Why - The Oracle Dispatch
Mon, 29 Jun 2020
Is Ibio Inc (IBIO) Stock Near the Top of the Biotechnology Industry? - InvestorsObserver
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE American |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
120 |
| Shares Float (M) |
102 |
|
% Held by Insiders
|
8.78 |
|
% Held by Institutions
|
11.56 |
|
Shares Short (K)
|
2,140 |
|
Shares Short P. Month (K)
|
2,840 |
Stock Financials |
|
EPS
|
-0.975 |
|
EPS Est This Year
|
-0.150 |
|
EPS Est Next Year
|
-0.200 |
|
Book Value (p.s.)
|
0.040 |
|
Profit Margin
|
|
|
Operating Margin
|
-1138.46 |
|
Return on Assets (ttm)
|
-24.0 |
|
Return on Equity (ttm)
|
-320.6 |
|
Qtrly Rev. Growth
|
-81.8 |
|
Gross Profit (p.s.)
|
0.017 |
|
Sales Per Share
|
0.011 |
|
EBITDA (p.s.)
|
-0.107 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-14 |
|
Levered Free Cash Flow (M)
|
-8 |
Stock Valuations |
|
PE Ratio
|
-2.01 |
|
PEG Ratio
|
|
|
Price to Book value
|
49.00 |
|
Price to Sales
|
179.24 |
|
Price to Cash Flow
|
-16.93 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
